)
Edge10 Jul 2026
Inside Take-Two: The Grand Anticipation
The story of how Take-Two Interactive built the empire behind Grand Theft Auto, Red Dead Redemption, and one of gaming's largest mobile portfolios.
Praxis Precision Medicines
Praxis Precision Medicines (PRAX) investor relations material
Praxis Precision Medicines Corporate presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Corporate presentation summary6 Aug, 2026
Mission and strategic vision
Focused on delivering life-altering treatments for CNS disorders with urgency and repeatability.
Aims to launch four CNS products with blockbuster potential by 2028, supported by a robust late-stage pipeline.
Projects a portfolio peak sales potential exceeding $20B, with cash runway into 2028.
Pipeline and innovation platforms
Pipeline includes ulixacaltamide (essential tremor), relutrigine (DEEs), elsunersen (early onset SCN2A DEE), and vormatrigine (epilepsy).
Utilizes Cerebrum™ (small molecule) and Solidus™ (ASO) platforms for precision CNS drug discovery.
Multiple programs have received Breakthrough Therapy, Orphan Drug, and Rare Pediatric Disease designations from FDA and EMA.
Clinical and commercial highlights
Ulixacaltamide demonstrated significant functional improvement in essential tremor, with positive Phase 3 results and PDUFA date in January 2027.
Relutrigine showed robust seizure reduction in DEEs, with NDA accepted and PDUFA in December 2026.
Elsunersen achieved marked seizure reduction in early onset SCN2A DEE, with ongoing pivotal trial.
Vormatrigine delivered best-in-disease efficacy in epilepsy, with broad applicability and favorable tolerability.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Praxis Precision Medicines
- Two late-stage NDAs near approval as cash reserves and commercial readiness strengthen.PRAX
Q2 20266 Aug 2026 - Multiple late-stage clinical readouts and $433.8M cash support operations into 2027.PRAXQ2 20249 Jul 2026
- Two NDAs filed, strong clinical data, and $1.5B cash position support 2026 launches.PRAXQ4 20259 Jul 2026
- Pivotal epilepsy studies and a robust pipeline set up multiple clinical catalysts through early 2026.PRAXJefferies Global Healthcare Conference 20259 Jul 2026
- Accelerated clinical and regulatory strategies are driving earlier market entry for key therapies.PRAXFireside Chat9 Jul 2026
- Q3 net loss was $51.9M; $411.2M cash funds late-stage CNS trials into 2027 with key data in 2025.PRAXQ3 20248 Jul 2026
- All proposals, including director elections and auditor ratification, were approved by shareholders.PRAXAGM 202610 Jun 2026
- Ulixacaltamide targets a vast unmet need in essential tremor, with a major launch imminent.PRAXGoldman Sachs 47th Annual Global Healthcare Conference 20268 Jun 2026
- Ulyxa and relumitragene advance toward launch with strong FDA continuity and broad commercialization plans.PRAXTD Cowen 46th Annual Health Care Conference18 May 2026
Next Praxis Precision Medicines earnings date
Q3 20266 Nov, 2026
Praxis Precision Medicines
Next Praxis Precision Medicines earnings date
Q3 20266 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage